2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 396.31

-0.6%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Secret_Agent_Man

sense

To: THE ANT who wrote (155824)	4/2/2020 11:34:15 PM
From: Dr. Voodoo	2 Recommendations of 218879

Hi Ant, Hard to say-- Azithromycin has been studied in COPD patients as an antiinflammatory. it does a lot of stuff. It's also known to interfere with transcription/translation etc. Too early too late in a pandemic when stuff is in short supply, first do no arm and 80% get better with nothing,,, its kind of a crapshoot IMO. I think they at least need to be symptomatic and probably should be given at first sign of breathing or lung obstruction, but I'm not sure when it's actually being given. FYI in my little corner of BKK they are already out of Pfizer brand Another poster asked me about quinolones. Here are a couple papers/reviews: ijidonline.com aafp.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next